Ilan Daskal - 08 Apr 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Chief Financial Officer
Signature: /s/ Ilan Daskal
Issuer symbol: BIO
Transactions as of: 08 Apr 2022
Net transactions value: -$153,470
Form type: 4
Filing time: 11 Apr 2022, 12:16:17 UTC
Previous filing: 08 Sep 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+700	+7778%	$0.000000	709	08 Apr 2022	Direct	F1
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$153,470	-257	-36%	$597.16	452	08 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-700	-33%	$0.000000	1,400	08 Apr 2022	Bio-Rad A Common Stock	700	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3	On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.